SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Peregrine Pharmaceuticals, Inc.( PPHM)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
3795 72 0 PPHM
Emcee:  Terry D. Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2995BusinessWeek: July 10, 1995 THE DARTS: FEAR, LOATHING, AND FOAM CUPS businessjessme-12/15/2010
2994Great investment guru that I am. The wife wanted to invest in DRI back in the miTerry D.-12/12/2010
2993One billion reasons why pharma R&D in China has reached the big leagues? biTerry D.-12/7/2010
2992<b>UTSW press release. More Proteins, clots, and Thorpe. </b>RefereTerry D.-12/6/2010
2991Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and throTerry D.-12/3/2010
2990Nice to see someone else is interested in Bavi in a combo treatment Hepatic Carjessme-12/1/2010
2989Peregrine Announces Initiation of Phase I/II Investigator-Sponsored Trial in LivTerry D.-12/1/2010
2988<b>Avid Bioservices to Present at IBC'S Antibody Engineering & TheTerry D.-11/29/2010
2987I wonder why Thorpe didn't mention bavi when the interviewer asked about newjessme-11/18/2010
2986What an interview. No PR though. Guess Amy is busy digging up more 2 year old dajessme-11/18/2010
2985<b> Thorpe speaks. You can listen to interview.</b> Original Air DatTerry D.-11/18/2010
2984I just don't see where today's PR shows any progress by the company. We Terry D.-11/17/2010
2983Peregrine's Bavituximab Demonstrates Broad Potential in Viral Hemorrhagic FeTerry D.-11/17/2010
2982Want a gas? Tustin keeps us so under the radar that a new ASCO 48 page report thTerry D.-11/16/2010
2981You'd think IR would at least acknowledge emails with a "Sorry, we are Terry D.-11/16/2010
2980Nice to see bavi mentioned and Thorpe interviewed.jessme-11/12/2010
2979Follow up interview with Thorpe from previous article. <b>An Interview WiTerry D.-11/12/2010
2978Bavituximab <b>One Step Closer To Antiviral Treatments for Persons InfecTerry D.-11/12/2010
2977<b>Journal of Commercial Biotechnology </b>(2010) 16, 279–280. doi:1Terry D.-11/9/2010
2976They should change the title of IR to NR (no response). I've written multipartp-11/7/2010
2975<b>I would like to see all the emails which have gone unanswered from variTerry D.-11/7/2010
2974Images from last post. Double click the images to get an enlarged view. I'mTerry D.-11/5/2010
2973PLoS One. 2010 Aug 6;5(8):e12031. <b>r84, a novel therapeutic antibody agTerry D.-11/5/2010
2972Imagine that. Having the CEO of a successful Biotech on your BOD. The CEO of MedTerry D.-11/4/2010
2971The only thing PPHM has demonstrated "proof of" is: cash burned, dilutEACarl-11/3/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News